Cytadren: And the Role of a Suppressant in Endocrine Therapy
Cytadren, or aminoglutethimide, is used primarily for managing Cushing’s syndrome and certain hormone-sensitive cancers like breast cancer. It works by inhibiting the enzyme aromatase, reducing hormone production, which can help in slowing tumor growth. Caution is advised due to potential side effects such as dizziness, drowsiness, and skin rash. Its use is typically monitored closely and considered when other treatments are ineffective.

